The following is a summary of “Factors associated with suspected nonmelanoma skin cancers, dysplastic nevus, and cutaneous melanoma among first-time SpotMe screening program participants during 2009-2010,” published in the JANUARY 2023 issue of Dermatology by Beaulieu, et al.
The variables connected to suspected basal cell carcinoma (BCC), squamous cell carcinoma (SCC), dysplastic nevus (DN), and cutaneous melanoma (CM) diagnosis had not been examined in studies of the American Academy of Dermatology’s SpotMe skin cancer screening program. Therefore, for a study, researchers sought to provide an overview of the demographics, risk factors, and access to care profiles related to BCC, SCC, DN, and CM probable diagnoses among first-time SpotMe screenees from 2009 to 2010.
Data from the 2009 and 2010 SpotMe skin cancer tests was used for a cross-sectional study. For each diagnosis, they conducted a multivariable logistic regression analysis, including co for each diagnosismmon demographic, access to care, and risk factor factors in the models.
For each probable diagnosis, men, those without a regular dermatologist, people reporting recently changed moles, and people with a personal history of melanoma were at higher risk. In addition, people without insurance had a higher likelihood of developing suspected cancer (BCC, SCC, and CM).
The probable diagnoses of BCC, SCC, DN, and CM among first-time SpotMe users shared significantly related characteristics that may be considered when organizing outreach and screening for groups at risk for skin cancer.